The Effectiveness of Heat Treatment on Knee Pain in Patients With Osteoarthritis - an International, Multicenter Clinical Investigation. Prospective, Open-label, One-arm, Post-market, Effectiveness Clinical Investigation

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This post-market clinical follow-up, open-label, multicenter clinical investigation is designed to investigate the effectiveness, safety and tolerability of ThermaCare® Knee Heatwraps in the painful knee joint due to osteoarthritis. Approximately 80 patients, 19-69 years old inclusive, with moderate knee osteoarthritis (without acute flares or inflammation) will be enrolled. The overall duration of the investigation is expected to be 11 days, including screening days. The maximum treatment duration for each patient is 7 days (8h/d).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 69
Healthy Volunteers: f
View:

• Signed written informed consent before inclusion in the investigation.

• Any gender, any ethnic origin, 19-69 years old inclusive.

• Body Mass Index 18.5-40 kg/m2 inclusive.

• Full comprehension: ability to comprehend the full nature and purpose of the clinical investigation.

• Patient with diagnosis of mono or bilateral moderate knee osteoarthritis with knee pain intensity \> 40 mm on a 0-100 mm VAS, able to independently ambulate without walking aid.

• Availability of a radiography of the selected knee not older than 6 months.

• Patient is either not of childbearing potential or must agree not to start a pregnancy from the signature of the informed consent up to the final visit

Locations
Other Locations
Switzerland
Ars Medica Clinic
RECRUITING
Gravesano
Contact Information
Primary
Rosita Molinario
rosita.molinario@angelinipharma.com
+39 3473243756
Backup
Enrica Salvatori
Enrica.salvatori@angelinipharma.com
+39 3458063168
Time Frame
Start Date: 2024-10-21
Estimated Completion Date: 2025-08-29
Participants
Target number of participants: 80
Treatments
Experimental: Group: Patients with moderate knee osteoarthritis
Patient without acute flares or inflammation enrolled. The overall duration of the investigation is expected to be 11 days, including screening days. The maximum treatment duration for each patient is 7 days (8h/d)
Related Therapeutic Areas
Sponsors
Leads: Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborators: Cross Research S.A.

This content was sourced from clinicaltrials.gov